Is the FDA to Blame for Your Bad Hip?

Don't let it get away!

Keep track of the stocks that matter to you.

Help yourself with the Fool's FREE and easy new watchlist service today.

Lawsuits are a way of life for any health-care company, a reality that's particularly evident in the medical-devices sector. For an example, you don't need to look any further than the orthopedic segment of the industry, which has been plagued in recent years by recalls of metal hip replacement components. From Zimmer's (UNKNOWN: ZMH.DL  ) recall of it's Durom Cup in 2008 to last year's announcements from Smith & Nephew (NYSE: SNN  ) and Stryker (NYSE: SYK  ) , it seems as if none of these companies was able to create technology that actually worked for patients.

But how can this be? Isn't the FDA supposed to make sure this type of thing doesn't happen? In the following video, Brenton Flynn walks through recent news from the highest-profile recall of them all, Johnson & Johnson (NYSE: JNJ  ) , and explains a key reason we've so many faulty hips implanted in patients over the years.

Is bigger really better?
Involved in everything from baby powder to biotech, Johnson & Johnson has its critics convinced that the company is spread way too thin. If you want to know whether J&J is nothing but a bloated corporate whale -- or a well-diversified giant that's perfect for your portfolio -- check out the Fool's new premium report outlining the Johnson & Johnson story in terms that any investor can understand. Claim your copy by clicking here now.

Read/Post Comments (1) | Recommend This Article (1)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On March 13, 2013, at 10:36 AM, jjjdepuy wrote:

    Many misinformed statements made in this video. For example, J&J didn't "pay" 8.3m - that was the judgment which will be appealed and will be settled for a much lower amount if not completely set aside. Also, FDA approval process for metal hips was not based on hips marketed before 1976 but rather based on a competitor’s product that did go through a rigorous PMA process. A majority of the people who have metal hips not only are problem free but they have improved the quality of their life tremendously. Yes, some have had problems, but it is disingenuous to suggest that “all” metal hips are bad.

Add your comment.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2308706, ~/Articles/ArticleHandler.aspx, 9/28/2016 1:34:40 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,207.37 -20.93 -0.11%
S&P 500 2,156.97 -2.96 -0.14%
NASD 5,292.57 -13.15 -0.25%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes